Minerva Neurosciences, Inc. Settlement Liabilities, Current
Minerva Neurosciences, Inc. (NERV) had Settlement Liabilities, Current of $23.80 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:SettlementLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Settlement Liabilities, Current $23.80K.
- 2026-03-31: Settlement Liabilities, Current $782.12K.
| Period end | Settlement Liabilities, Current |
|---|---|
| 2026-06-30 | $23.80K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $782.12K 10-Q · filed 2026-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |